Browse Newsroom

InsuLife 2022 Spring Investor Seminar

March 25, 2022

> Download PDF Invitation <


 Oslo Science Park - Meeting Room: Hagen 3 Gaustadalléen 21, Oslo, Norway


 14.00 - Welcome 

14.05 - Prof. Akhtar Hussain: Insulin global cost & distribution challenges 

14:25 - Dr. Chandan Alam: InsuLife technology 

14:45 - Dr. Nicola Kingswell: Transdermal route with INS-2301 

// Coffee Break // 

15:15 - Karita Bekkemellem: Pharmaceutical industry in Norway 

15:25 - Knut Smerud: Plan for phase 1 clinical study in Norway 

15:40 - Åge Nærdal: Path forward for InsuLife 

15:50 - Q&A 


How to Register

 To register for this seminar please RSVP to 

Please indicate if you will be attending in person or via live stream. 

Subscribe for InsuLife News Updates
Sign up to receive the latest InsuLife news, updates and investing information delivered right to your inbox.
Newsletter Form (#1)
InsuLife is a Norwegian company aiming at bringing the unparalleled developmental INS-2301 skin-applied insulin to market.
Learn More
© Copyright 2024 - InsuLife AS, All Rights Reserved